All wild speculation but, let’s say Roche have already seen enough.
They are happy to enter into a licensing agreement or big money TO for their desired combination option.
It is conditional on Merck not being in the room, at all.
Or there is a company pivot towards what would appear to be our shining treatment star and we are going all in there.
Like others, I do not feel this Ann is in isolation. I expect subsequent announcements to be near term and highly positive. Feels like the real game is about to begin
Ann: Termination of Supply Agreement, page-77
-
- There are more pages in this discussion • 372 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(8.33%) |
Mkt cap ! $422.5M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.455M | 25.41M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 307797 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 714787 | 15 |
View Market Depth
| Last trade - 15.56pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |